Skip to main content

Table 2 Correlation between the number and microlocalization of immune cells and patient's survival time by a univariate analysis

From: The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer

Cell type Islets + Stroma Islets Stroma P (islets versus stroma)
  Number Spearman's rho & P Number Spearman's rho & P Number Spearman's rho & P  
Macrophages 15.2
(1.8 - 48.4)
rs = -0.105
P = 0.300
4.2
(0.2 - 40.6)
rs = 0.483
P = 0.000
7.2
(0.4 - 39.6)
rs = -0.541
P = 0.000
0.040
Mature dendritic cells 13.2
(1.4 - 137.6)
rs = 0.221
P = 0.028
4.2
(0 - 21.4)
rs = 0.404
P = 0.001
7.0
(0.2 - 25.4)
rs = 0.284
P = 0.045
0.000
CD8+ T cells 10.8
(0.4 - 45.0)
rs = 0.297
P = 0.003
4.2
(0 - 66.2)
rs = 0.247
P = 0.014
7.2
(0.2 - 71.4)
rs = 0.212
P = 0.035
0.032
  1. The number of immune cells represents median (range) per high-power field. The number of immune cells in the tumor islets and stroma (Islets + Stroma) was obtained by combining the number in the tumor islets and the number in the tumor stroma in each case. Then, the numbers of immune cells in the tumor islets and stroma were ranked and the median number was determined. Therefore, the median number of immune cells in the tumor islets and stroma is not a simple sum of the median number in the tumor islets and the median number in the tumor stroma as shown in this table.